HOB Biotech GroupLtd Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
HOB Biotech GroupLtd has a total shareholder equity of CN¥806.0M and total debt of CN¥105.1M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are CN¥1.0B and CN¥196.8M respectively. HOB Biotech GroupLtd's EBIT is CN¥41.6M making its interest coverage ratio 35.5. It has cash and short-term investments of CN¥105.1M.
Wichtige Informationen
13.0%
Verhältnis von Schulden zu Eigenkapital
CN¥105.05m
Verschuldung
| Zinsdeckungsgrad | 35.5x |
| Bargeld | CN¥105.13m |
| Eigenkapital | CN¥806.03m |
| Gesamtverbindlichkeiten | CN¥196.80m |
| Gesamtvermögen | CN¥1.00b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Recent updates
Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08
Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 688656's short term assets (CN¥282.5M) exceed its short term liabilities (CN¥184.0M).
Langfristige Verbindlichkeiten: 688656's short term assets (CN¥282.5M) exceed its long term liabilities (CN¥12.8M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 688656 has more cash than its total debt.
Schulden abbauen: 688656's debt to equity ratio has reduced from 29% to 13% over the past 5 years.
Schuldendeckung: 688656's debt is well covered by operating cash flow (102.3%).
Zinsdeckung: 688656's interest payments on its debt are well covered by EBIT (35.5x coverage).